PDCD1 and cancer: Circulating EVs have been suggested to be mediators utilised by cancer cells to promote immune escape, by transporting PD1 and PD-L1 and changing the phenotypic characteristics of different immune cell populations such as T cells, DCs and macrophages [8, 31–34, 38–40, 47, 50, 51].